Literature DB >> 4787618

Effect of route of administration on drug disposition.

S Riegelman, M Rowland.   

Abstract

Mesh：

Substances：

Year:  1973        PMID： 4787618     DOI： 10.1007/bf01059666

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN： 0090-466X


× No keyword cloud information.
  27 in total

1.  RELATIONS OF RATE OF ABSORPTION AND PLASMA CORTISOL CONCENTRATION.

Authors:  H P SCHEDL; J A CLIFTON; G NOKES
Journal:  J Clin Endocrinol Metab       Date:  1964-02       Impact factor: 5.958

2.  The effect of splanchnic sympathectomy in hypertensive patients upon estimated hepatic blood flow in the upright as contrasted with the horizontal position.

Authors:  R W WILKINS; J W CULBERTSON; F J INGELFINGER
Journal:  J Clin Invest       Date:  1951-03       Impact factor: 14.808

3.  Plasma concentrations of propoxyphene in man. I. Following oral administration of the drug in solution and capsule forms.

Authors:  J G Wagner; P G Welling; S B Roth; E Sakmar; K P Lee; J E Walker
Journal:  Int Z Klin Pharmakol Ther Toxikol       Date:  1972-02

4.  Absorption kinetics of aspirin in man following oral administration of an aqueous solution.

Authors:  M Rowland; S Riegelman; P A Harris; S D Sholkoff
Journal:  J Pharm Sci       Date:  1972-03       Impact factor: 3.534

5.  Influence of route of administration on drug availability.

Authors:  M Rowland
Journal:  J Pharm Sci       Date:  1972-01       Impact factor: 3.534

6.  Pharmacokinetics and biological effects of nortriptyline in man.

Authors:  F Sjöqvist; B Alexanderson; M Asberg; L Bertilsson; O Borgå; B Hamberger; D Tuck
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1971

7.  Shortcomings in pharmacokinetic analysis by conceiving the body to exhibit properties of a single compartment.

Authors:  S Riegelman; J C Loo; M Rowland
Journal:  J Pharm Sci       Date:  1968-01       Impact factor: 3.534

8.  Intestinal drug absorption and metabolism. II. Kinetic aspects of intestinal glucuronide conjugation.

Authors:  W H Barr; S Riegelman
Journal:  J Pharm Sci       Date:  1970-02       Impact factor: 3.534

Review 9.  Hepatic vascular bed.

Authors:  C V Greenway; R D Stark
Journal:  Physiol Rev       Date:  1971-01       Impact factor: 37.312

10.  Quantitative determination of drug bioavailability and biokinetic behavior from pharmacological data for ophthalmic and oral administrations of a mydriatic drug.

Authors:  V F Smolen
Journal:  J Pharm Sci       Date:  1971-03       Impact factor: 3.534
View more
  11 in total

1.  Comparison of oral and intravenous methylphenidate.

Authors:  D S Janowsky; P Leichner; P Clopton; L L Judd; D Parker; L Huey
Journal:  Psychopharmacology (Berl)       Date:  1978-09-15       Impact factor: 4.530

2.  Quantitation of hepatic and pulmonary first-pass effects and its implications in pharmacokinetic study. I. Pharmacokinetics of chloroform in man.

Authors:  W L Chiou
Journal:  J Pharmacokinet Biopharm       Date:  1975-06

3.  Physiological modeling to understand the impact of enzymes and transporters on drug and metabolite data and bioavailability estimates.

Authors:  Huadong Sun; K Sandy Pang
Journal:  Pharm Res       Date:  2010-04-06       Impact factor: 4.200

4.  Induction of drug metabolism in man after rifampicin treatment measured by increased hexobarbital and tolbutamide clearance.

Authors:  W Zilly; D D Breimer; E Richter
Journal:  Eur J Clin Pharmacol       Date:  1975-12-19       Impact factor: 2.953

5.  Ergot alkaloids: hepatic distribution and estimation of absorption by measurement of total radioactivity in bile and urine.

Authors:  F Nimmerfall; J Rosenthaler
Journal:  J Pharmacokinet Biopharm       Date:  1976-02

6.  Importance of "first-pass elimination" for interindividual differences in steady-state concentrations of the adrenergic beta-receptor antagonist alprenolol.

Authors:  G Alván; M Lind; B Mellström; C von Bahr
Journal:  J Pharmacokinet Biopharm       Date:  1977-06

7.  Model independent derivation of general equations for the "first-pass" effect and extra-hepatic drug elimination.

Authors: 
Journal:  Eur J Clin Pharmacol       Date:  1977       Impact factor: 2.953

8.  Theoretical considerations in the calculation of bioavailability of drugs exhibiting Michaelis-Menten elimination kinetics.

Authors:  G M Rubin; T N Tozer
Journal:  J Pharmacokinet Biopharm       Date:  1984-08

Review 9.  Rectal drug administration: clinical pharmacokinetic considerations.

Authors:  A G de Boer; F Moolenaar; L G de Leede; D D Breimer
Journal:  Clin Pharmacokinet       Date:  1982 Jul-Aug       Impact factor: 6.447

10.  Pharmacokinetics of lorcainide in man: a new antiarrhythmic agent.

Authors:  U Klotz; P Müller-Seydlitz; P Heimburg
Journal:  Clin Pharmacokinet       Date:  1978 Sep-Oct       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.